New eye injection enters human testing for Diabetes-Related vision loss
NCT ID NCT05802329
Summary
This is a first-in-human study to check the safety and early signs of effectiveness of a new eye injection called OCU200 for diabetic macular edema, a condition that causes vision loss. The study will enroll up to 24 adults with diabetes and vision loss from this specific eye swelling. Participants will receive two injections of the drug into the eye, six weeks apart, while doctors closely monitor for side effects and any changes in vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advanced Research LLC
RECRUITINGDeerfield Beach, Florida, 33064, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Erie Retina Research, LLC
RECRUITINGErie, Pennsylvania, 16507, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Gundersen Health System
RECRUITINGLa Crosse, Wisconsin, 54601, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Retina Consultants of America
RECRUITINGSouthlake, Texas, 76092, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Retina Consultants of Texas Research Centers
RECRUITINGBellaire, Texas, 77401, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.